211 related articles for article (PubMed ID: 38484857)
1. Copper homeostasis in chronic kidney disease and its crosstalk with ferroptosis.
Jiayi H; Ziyuan T; Tianhua X; Mingyu Z; Yutong M; Jingyu W; Hongli Z; Li S
Pharmacol Res; 2024 Apr; 202():107139. PubMed ID: 38484857
[TBL] [Abstract][Full Text] [Related]
2. Role of ferroptosis in chronic kidney disease.
Li S; Han Q; Liu C; Wang Y; Liu F; Pan S; Zuo L; Gao D; Chen K; Feng Q; Liu Z; Liu D
Cell Commun Signal; 2024 Feb; 22(1):113. PubMed ID: 38347570
[TBL] [Abstract][Full Text] [Related]
3. [Pathogenesis of ferroptosis on chronic kidney disease and traditional Chinese medicine intervention: a review].
Yang BY; Liu X; Hu S; Peng YJ; Zhang WN; Liu BL; He ZY
Zhongguo Zhong Yao Za Zhi; 2024 May; 49(10):2629-2639. PubMed ID: 38812163
[TBL] [Abstract][Full Text] [Related]
4. Ferroptosis As a Mechanism for Health Effects of Essential Trace Elements and Potentially Toxic Trace Elements.
Xu Y; Chen R; Zeng Q
Biol Trace Elem Res; 2023 Sep; 201(9):4262-4274. PubMed ID: 36575272
[TBL] [Abstract][Full Text] [Related]
5. The role of ferroptosis in the development of acute and chronic kidney diseases.
Zhou Y; Zhang J; Guan Q; Tao X; Wang J; Li W
J Cell Physiol; 2022 Dec; 237(12):4412-4427. PubMed ID: 36260516
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of ferroptosis in chronic kidney disease.
Zhuo WQ; Wen Y; Luo HJ; Luo ZL; Wang L
Front Mol Biosci; 2022; 9():975582. PubMed ID: 36090053
[TBL] [Abstract][Full Text] [Related]
7. Ferroptosis, a new target for treatment of renal injury and fibrosis in a 5/6 nephrectomy-induced CKD rat model.
Wang J; Wang Y; Liu Y; Cai X; Huang X; Fu W; Wang L; Qiu L; Li J; Sun L
Cell Death Discov; 2022 Mar; 8(1):127. PubMed ID: 35318301
[TBL] [Abstract][Full Text] [Related]
8. Broadening horizons: the multifaceted functions of ferroptosis in kidney diseases.
Feng Q; Yang Y; Ren K; Qiao Y; Sun Z; Pan S; Liu F; Liu Y; Huo J; Liu D; Liu Z
Int J Biol Sci; 2023; 19(12):3726-3743. PubMed ID: 37564215
[TBL] [Abstract][Full Text] [Related]
9. Vitexin attenuates chronic kidney disease by inhibiting renal tubular epithelial cell ferroptosis via NRF2 activation.
Song J; Wang H; Sheng J; Zhang W; Lei J; Gan W; Cai F; Yang Y
Mol Med; 2023 Oct; 29(1):147. PubMed ID: 37891461
[TBL] [Abstract][Full Text] [Related]
10. Abnormal Iron and Lipid Metabolism Mediated Ferroptosis in Kidney Diseases and Its Therapeutic Potential.
Zhang X; Li X
Metabolites; 2022 Jan; 12(1):. PubMed ID: 35050181
[TBL] [Abstract][Full Text] [Related]
11. Emerging Role of Ferroptosis in Diabetic Kidney Disease: Molecular Mechanisms and Therapeutic Opportunities.
Wang H; Liu D; Zheng B; Yang Y; Qiao Y; Li S; Pan S; Liu Y; Feng Q; Liu Z
Int J Biol Sci; 2023; 19(9):2678-2694. PubMed ID: 37324941
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic Implications of Ferroptosis in Renal Fibrosis.
Zhang Y; Mou Y; Zhang J; Suo C; Zhou H; Gu M; Wang Z; Tan R
Front Mol Biosci; 2022; 9():890766. PubMed ID: 35655759
[TBL] [Abstract][Full Text] [Related]
13. Targeting ferroptosis in acute kidney injury.
Ni L; Yuan C; Wu X
Cell Death Dis; 2022 Feb; 13(2):182. PubMed ID: 35210424
[TBL] [Abstract][Full Text] [Related]
14. The Road from AKI to CKD: Molecular Mechanisms and Therapeutic Targets of Ferroptosis.
Guo R; Duan J; Pan S; Cheng F; Qiao Y; Feng Q; Liu D; Liu Z
Cell Death Dis; 2023 Jul; 14(7):426. PubMed ID: 37443140
[TBL] [Abstract][Full Text] [Related]
15. Benefits and risks of essential trace elements in chronic kidney disease: a narrative review.
Xie Y; Liu F; Zhang X; Jin Y; Li Q; Shen H; Fu H; Mao J
Ann Transl Med; 2022 Dec; 10(24):1400. PubMed ID: 36660676
[TBL] [Abstract][Full Text] [Related]
16. Fisetin ameliorates fibrotic kidney disease in mice via inhibiting ACSL4-mediated tubular ferroptosis.
Wang B; Yang LN; Yang LT; Liang Y; Guo F; Fu P; Ma L
Acta Pharmacol Sin; 2024 Jan; 45(1):150-165. PubMed ID: 37696989
[TBL] [Abstract][Full Text] [Related]
17. Ferroptosis in renal fibrosis: a mini-review.
Yang SQ; Zhao X; Zhang J; Liao DY; Wang YH; Wang YG
J Drug Target; 2024 May; ():1-9. PubMed ID: 38721679
[TBL] [Abstract][Full Text] [Related]
18. Research progress on ferroptosis in diabetic kidney disease.
Wu Y; Chen Y
Front Endocrinol (Lausanne); 2022; 13():945976. PubMed ID: 36246888
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Indoxyl Sulfate-Induced Reactive Oxygen Species-Related Ferroptosis Alleviates Renal Cell Injury In Vitro and Chronic Kidney Disease Progression In Vivo.
Tsai LT; Weng TI; Chang TY; Lan KC; Chiang CK; Liu SH
Antioxidants (Basel); 2023 Oct; 12(11):. PubMed ID: 38001784
[TBL] [Abstract][Full Text] [Related]
20. Ferroptosis and cuproptposis in kidney Diseases: dysfunction of cell metabolism.
Chen T; Liang L; Wang Y; Li X; Yang C
Apoptosis; 2024 Apr; 29(3-4):289-302. PubMed ID: 38095762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
